204 related articles for article (PubMed ID: 29380706)
1. Anticancer Activity Study of Chromone and Coumarin Hybrids using Electrical Impedance Spectroscopy.
Bouhenna MM; Mameri N; Pérez MV; Talhi O; Bachari K; Silva AMS; Luyten W
Anticancer Agents Med Chem; 2018; 18(6):854-864. PubMed ID: 29380706
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif.
Dlugosz A; Gach-Janczak K; Szymanski J; Deredas D; Krawczyk H; Janecki T; Janecka A
Anticancer Agents Med Chem; 2018; 18(3):450-457. PubMed ID: 28933263
[TBL] [Abstract][Full Text] [Related]
3. Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents.
Chen Y; Liu HR; Liu HS; Cheng M; Xia P; Qian K; Wu PC; Lai CY; Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
Eur J Med Chem; 2012 Mar; 49():74-85. PubMed ID: 22265685
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Elshemy HAH; Zaki MA
Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
[TBL] [Abstract][Full Text] [Related]
5. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
Ma CC; Liu ZP
Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
[TBL] [Abstract][Full Text] [Related]
6. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
7. Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII.
Bonardi A; Falsini M; Catarzi D; Varano F; Di Cesare Mannelli L; Tenci B; Ghelardini C; Angeli A; Supuran CT; Colotta V
Eur J Med Chem; 2018 Feb; 146():47-59. PubMed ID: 29407972
[TBL] [Abstract][Full Text] [Related]
8. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR
Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057
[TBL] [Abstract][Full Text] [Related]
9. Coumarin derivatives with anticancer activities: An update.
Song XF; Fan J; Liu L; Liu XF; Gao F
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
[TBL] [Abstract][Full Text] [Related]
11. DNA-binding activity and cytotoxic and cell-cycle arrest properties of some new coumarin derivatives: a multispectral and computational investigation.
Khosravifar F; Dehghan G; Bidoki SK; Mahdavi M
Luminescence; 2020 Feb; 35(1):98-106. PubMed ID: 31475787
[TBL] [Abstract][Full Text] [Related]
12. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential.
Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S
Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
Ayati A; Oghabi Bakhshaiesh T; Moghimi S; Esmaeili R; Majidzadeh-A K; Safavi M; Firoozpour L; Emami S; Foroumadi A
Eur J Med Chem; 2018 Jul; 155():483-491. PubMed ID: 29908441
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.
Stanica L; Gheorghiu M; Stan M; Polonschii C; David S; Bratu D; Dinischiotu A; Supuran CT; Gheorghiu E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1079-1090. PubMed ID: 28783982
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
Yu H; Hou Z; Tian Y; Mou Y; Guo C
Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.
Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Kumar CG; Pombala S; Sridhar B
Eur J Med Chem; 2014 May; 79():260-5. PubMed ID: 24742385
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antiproliferative activities, and DNA binding of coumarin-3-formamido derivatives.
Shi J; Lu W; Chen J; Sun L; Yang S; Zhou M; Xu L; Ma Y; Yu L
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000236. PubMed ID: 33079446
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
Ji H; Tan Y; Gan N; Zhang J; Li S; Zheng X; Wang Z; Yi W
Bioorg Med Chem; 2021 Jan; 29():115870. PubMed ID: 33221062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]